Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Eli Lilly & Co. (LLY) Tops Q3 EPS by 7c; Offers FY22 EPS Guidance
November 1, 2022 6:27 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.91 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.70-$7.85, versus the... More
